Sunday, 26 January 2020

Clinical Research News

  • Breast cancer drug market to touch $13.1 bn by 2020'

    Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Increased use of targeted therapies, along with a greater uptake of branded drugs and rising incidence population, will cause the breast cancer therapeutics market value to grow ...Read more

  • Liposome to begin phase-II trials for its cancer drug

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2014

    Singapore: Taiwan-based drugmaker, Liposome announced that it had received approval from the Chinese government to begin second-phase clinical trials for its new drug, Lipotecan, that treat...Read more

  • Drug development challenges and opportunities in Asia

    Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2014

    Singapore: Approximately 15 years ago, PAREXEL envisioned Asia would becomean important player in clinical research and drug development, followed by Eastern and Central Europe. Asia's arri...Read more

  • Malaysia urges graduates to pursue clinical research

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Malaysia is making efforts to develop expertise in various scientific and clinical disciplines among its graduates and to consider involvement in clinical research as a career op...Read more

  • Novartis finds no evidence of wrongdoing in clinical trials

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had been manipulated, the company said in a report. Mr Yoshiyasu Ninomiya,...Read more

  • Oramed, Medpace CRO join hands for oral insulin trial

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

    Singapore: Oramed Pharmaceuticals subsidiary signed an agreement to retain Medpace as the clinical research organization (CRO) for Oramed's upcoming phase II clinical trial on its oral insu...Read more

  • Study finds 600 new genes mutated in stomach cancer

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Singapore: A collaborative study conducted by three research groups affiliated with the Duke-NUS Graduate Medical School (Duke-NUS) and the National Cancer Center Singapore (NCCS) has ident...Read more

  • Sigma-Aldrich unit enters Korea with CrystalGenomics

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: Sigma-Aldrich's custom manufacturing and services business unit, SAFC, has signed an agreement with Seoul-based CrystalGenomics to support the development of active pharmaceutica...Read more

  • India approved 26 drugs without clinical trials

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    New Delhi: Officials in the Indian health ministry have admitted that about 26 new drug molecules were given approval since 2010 without conducting any proper clinical trials on local popul...Read more

  • FDA offers guidance on Alzheimer's drug development

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

    Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before t...Read more

  • SIRO wins Frost & Sullivan CRO award

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Mumbai: SIRO Clinpharm has been awarded the Indian Clinical Research Organization of the Year 2012 Award by Frost & Sullivan, a leading global growth partnership and consulting firm. Th...Read more

  • Clinical Research Network gives Singapore its competitive edge

    Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore has a good track record of conducting high quality clinical trials in Asia, attributed to the highly qualified doctors and clinical trials coordinators who are trained in Good C...Read more

  • Mr Denzil Benjamin, ICON: New guidelines by India's CDSCO will re-define the industry in 2013

    Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    Adapting technology and tools to address the issues of increasing research and development (R&D) costs, slow results, lack of funding, regulatory requirements, multiple databases, and s...Read more

  • India strengthens clinical trial regulations

    Clinical Research |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian government has announced several measures. Union Minister for Health and Family Welfare Mr...Read more

  • PAREXEL inks services deal with Taiwan hospital

    Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Taiwan's PAREXEL International, a biopharmaceutical services provider, and National Taiwan University Hospital (NTUH) have collaborated to provide drug development services in Ta...Read more

  • Merger and Acquisition in CRO-Annual BSA CRO Survey

    Clinical Research |  Analysis | By Nandita Singh | 0 Comment | 11 Oct, 2015

    According to business intelligence provider, GBI Research, total number of deals in the global contract research organization market reached 700 between January 2010 and April 2015, achievi...Read more

  • Fight between local and global CROs intensifies

    Clinical Research |  Influencers | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2012

    Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special responsibility for the growth and development in Asia Pacific (APA C)....Read more

  • Malaysia to build on its clinical research potential

    Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Malaysia's aspiration is to be a developed nation by the year 2020. With 10 years more to prepare for this anticipated year, current Prime Minister Datuk Seri Mohd Najib Tun Razak announc...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls